These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22051974)

  • 1. Anti-tumor activity of immunomodulatory peptide alloferon-1 in mouse tumor transplantation model.
    Chernysh S; Irina K; Irina A
    Int Immunopharmacol; 2012 Jan; 12(1):312-4. PubMed ID: 22051974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor activity of a peptide combining patterns of insect alloferons and mammalian immunoglobulins in naïve and tumor antigen vaccinated mice.
    Chernysh S; Kozuharova I
    Int Immunopharmacol; 2013 Dec; 17(4):1090-3. PubMed ID: 24183654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral and antitumor peptides from insects.
    Chernysh S; Kim SI; Bekker G; Pleskach VA; Filatova NA; Anikin VB; Platonov VG; Bulet P
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):12628-32. PubMed ID: 12235362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing effect of new biological response modifier sulfoethylated (1-->3)-beta-D-glucan on antitumor activity of cyclophosphamide in the treatment of experimental murine leukoses.
    Khalikova TA; Korolenko TA; Zhanaeva SY; Kaledin VI; Kogan G
    Exp Oncol; 2006 Dec; 28(4):308-13. PubMed ID: 17285116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.
    Li LH; DeKoning TF; Wallace TL
    Cancer Res; 1987 Nov; 47(22):5894-900. PubMed ID: 3664490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synergistic role between rhIL-2 and adriamycin long circulating temperature-sensitive liposome in targeting therapy on tumor].
    Dong LF; Mei HS; Song SX; Lu ZJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May; 21(3):296-300. PubMed ID: 15862144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of orally administered glycogen on anti-tumor activity and natural killer cell activity in mice.
    Kakutani R; Adachi Y; Kajiura H; Takata H; Kuriki T; Ohno N
    Int Immunopharmacol; 2012 Jan; 12(1):80-7. PubMed ID: 22080051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulation of proliferation and viability of tumor cells in vitro by alloferon-1 and allostatin-1].
    Pleskach VA; Kozhukharova IV; Alekseenko LL; Pleskach NM; Anikin VB; Chernysh SI
    Tsitologiia; 2011; 53(3):250-8. PubMed ID: 21598688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model.
    Saucier JM; Yu J; Gaikwad A; Coleman RL; Wolf JK; Smith JA
    J Oncol Pharm Pract; 2007 Mar; 13(1):39-45. PubMed ID: 17621566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of the anti-tumor efficacy of a GM-CSF-secreting tumor cell immunotherapy in preclinical models by cytosine arabinoside.
    Lin JM; Li B; Rimmer E; VanRoey M; Jooss K
    Exp Hematol; 2008 Mar; 36(3):319-28. PubMed ID: 18279719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
    Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
    J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-tumor effect of monkshood polysaccharide with adriamycin long circulating temperature-sensitive liposome and its mechanism].
    Dong LF; Zhang YJ; Liu JS; Song SX; Hou J; Lu ZJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):458-62. PubMed ID: 16806008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical antitumor activity of penclomedine in mice: cross-resistance, schedule dependence, and oral activity against tumor xenografts in brain.
    Harrison SD; Plowman J; Dykes DJ; Waud WR; Griswold DP
    Cancer Res; 1991 Apr; 51(8):1979-83. PubMed ID: 2009516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superior antitumor activity of SAR3419 to rituximab in xenograft models for non-Hodgkin's lymphoma.
    Al-Katib AM; Aboukameel A; Mohammad R; Bissery MC; Zuany-Amorim C
    Clin Cancer Res; 2009 Jun; 15(12):4038-45. PubMed ID: 19509168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor efficacy of Cloretazine (VNP40101M) alone and in combination with fludarabine in murine tumor and human xenograft tumor models.
    Zheng LM; Li Z; Liu L; Song BL; King I
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):45-51. PubMed ID: 17256135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.
    Li LH; Wallace TL; Richard KA; Tracey DE
    Cancer Res; 1985 Feb; 45(2):532-8. PubMed ID: 3967227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The cross resistance to cytostatics of leukemia P388 cells with induced resistance to doxorubicin].
    Donenko FV; Sitdikova SM; Kabieva AO
    Biull Eksp Biol Med; 1993 Sep; 116(9):309-11. PubMed ID: 8118011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of the acquired immune system in successful cancer chemotherapy with cis-diamminedichloroplatinum (II) in a syngeneic mouse tumor transplantation model.
    Taniguchi K; Nishiura H; Yamamoto T
    J Immunother; 2011; 34(6):480-9. PubMed ID: 21654518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of biological response modifiers against transplantable mouse tumors of spontaneous origin. I. Characterization of biological properties of tumor lines and preliminary data on response to cytostatic drugs and biomodulators.
    Fiszer-Maliszewska L; Mordarski M; Madej JA
    Arch Immunol Ther Exp (Warsz); 1993; 41(1):1-9. PubMed ID: 8239902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
    Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
    Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.